[Federal Register Volume 66, Number 96 (Thursday, May 17, 2001)]
[Notices]
[Page 27524]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-12469]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Complementary and Alternative Medicine; 
Notice of Meeting

    Pursuant to Section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the Cancer 
Advisory Panel for Complementary and Alternative Medicine (CAPCAM).
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.


    Name of Committee: Cancer Advisory Panel for Complementary and 
Alternative Medicine.
    Date: May 21, 2001.
    Open: May 21, 2001, 9:00 am to adjournment.
    Agenda: The agenda will include a report on clinical trial data 
on Virulizen (R), an update on the Rand BSC Approach to BCS, an 
update on NIH initiatives for CAM and Cancer treatments, and other 
business of the Panel.
    Place: Pooks Hill Marriott, 5151 Pooks Hill Road, Bethesda, MD 
20814.
    Contact Person: Richard Nahin, Ph.D., Executive Secretary, 
National Center for Complementary and Alternative Medicine, National 
Institutes of Health, 6707 Democracy Blvd, Suite 106, Bethesda, MD 
20892, 301/496-7801.
    The public comments session is scheduled on May 21 from 3:00 pm 
to 3:30 pm. Each speaker will be permitted 5 minutes for their 
presentation. Interested individuals and representatives of 
organizations are requested to notify Dr. Richard Nahin, National 
Center for Complementary and Alternative Medicine, NIH, 6707 
Democracy Blvd, Suite 106, Bethesda, Maryland 20892, 301-496-7801, 
Fax 301-480-3621. Letters of intent to present comments, along with 
a brief description of the organization represented, should be 
received no later than 5:00 pm May 15, 2001. Only one representative 
of an organization may present oral comments. Any person attending 
the meeting who does not request an opportunity to speak in advance 
of the meeting may be considered for oral presentation, if time 
permits, and at the discretion of the Chairperson. In addition, 
written comments may be submitted to Dr. Nahin at the address listed 
above up to ten calendar days (May 31, 2001) following the meeting.
    Copies of the meeting agenda and the roster of members will be 
furnished upon request by Dr. Richard Nahin, Executive Secretary, 
CAPCAM, National Institutes of Health, 6707 Democracy Blvd, Suite 
106, Bethesda, Maryland 20892, 301 496-7801, Fax 301-480-3621.
    This meeting is being published less than 15 days prior to the 
meeting due to scheduling conflicts.


    Dated: May 9, 2001.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy, NIH.
[FR Doc. 01-12469 Filed 5-16-01; 8:45 am]
BILLING CODE 4140-01-M